David Schiff

3.4k total citations
69 papers, 1.9k citations indexed

About

David Schiff is a scholar working on Law, Genetics and Neurology. According to data from OpenAlex, David Schiff has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Law, 18 papers in Genetics and 12 papers in Neurology. Recurrent topics in David Schiff's work include Glioma Diagnosis and Treatment (17 papers), Law in Society and Culture (13 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). David Schiff is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Law in Society and Culture (13 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). David Schiff collaborates with scholars based in United Kingdom, United States and Canada. David Schiff's co-authors include Lisa M. DeAngelis, Richard Nobles, Lauren E. Abrey, Jeffrey J. Raizer, Rose Lai, Gaurav Shah, Denise D. Correa, Joachim Yahalom, Barbara Grant and Patrick Y. Wen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

David Schiff

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Schiff United Kingdom 18 971 865 814 332 296 69 1.9k
Amanda Termuhlen United States 25 286 0.3× 305 0.4× 418 0.5× 438 1.3× 234 0.8× 74 1.8k
Farshad Nassiri Canada 29 537 0.6× 618 0.7× 627 0.8× 273 0.8× 461 1.6× 96 3.0k
James P. Chandler United States 24 497 0.5× 783 0.9× 118 0.1× 157 0.5× 402 1.4× 108 1.8k
Rachel Pearce United Kingdom 20 435 0.4× 362 0.4× 753 0.9× 584 1.8× 177 0.6× 46 1.5k
Christine M. Fisher United States 24 938 1.0× 127 0.1× 235 0.3× 688 2.1× 329 1.1× 95 3.0k
Eng‐Siew Koh Australia 19 116 0.1× 265 0.3× 315 0.4× 279 0.8× 512 1.7× 69 1.3k
John Amess United Kingdom 12 124 0.1× 358 0.4× 619 0.8× 445 1.3× 98 0.3× 16 1.3k
Sharon L. Gardner United States 28 889 0.9× 1.6k 1.8× 225 0.3× 264 0.8× 635 2.1× 101 2.6k
Anne‐Sophie Michallet France 22 112 0.1× 728 0.8× 771 0.9× 362 1.1× 148 0.5× 93 1.5k
Simonetta Viviani Italy 33 1.2k 1.2× 755 0.9× 3.2k 3.9× 1.9k 5.6× 1.2k 4.0× 119 4.4k

Countries citing papers authored by David Schiff

Since Specialization
Citations

This map shows the geographic impact of David Schiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schiff more than expected).

Fields of papers citing papers by David Schiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Schiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schiff. The network helps show where David Schiff may publish in the future.

Co-authorship network of co-authors of David Schiff

This figure shows the co-authorship network connecting the top 25 collaborators of David Schiff. A scholar is included among the top collaborators of David Schiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Schiff. David Schiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dmello, Crismita, Andrew Brenner, David Piccioni, et al.. (2024). Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma. Neuro-Oncology Advances. 6(1). vdae186–vdae186. 6 indexed citations
2.
Schiff, David, Anne O’Neill, Paul D. Brown, et al.. (2024). LTBK-07. PROGRESSION-FREE AND OVERALL SURVIVAL RESULTS OF ECOG-ACRIN E3F05: A PHASE 3 INTERGROUP TRIAL OF RADIATION ± TEMOZOLOMIDE FOR GRADE II GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii1–viii2. 4 indexed citations
3.
4.
Schiff, David, Ranjit S. Bindra, Jing Li, et al.. (2023). CTNI-41. PHASE II AND PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. Neuro-Oncology. 25(Supplement_5). v84–v84. 3 indexed citations
5.
Avila, Edward K., Steven Tobochnik, Sara K. Inati, et al.. (2023). Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management. Neuro-Oncology. 26(1). 7–24. 33 indexed citations
6.
Schiff, David. (2019). The Ellington Century.
7.
Fezeu, Francis, et al.. (2015). Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West Africa. Cureus. 7(11). e372–e372. 11 indexed citations
8.
Morris, Patrick G., Denise D. Correa, Joachim Yahalom, et al.. (2013). Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome. Journal of Clinical Oncology. 31(31). 3971–3979. 316 indexed citations
9.
Evens, Andrew M., Sylvain Choquet, Aimee Kroll‐Desrosiers, et al.. (2013). Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era. American Journal of Transplantation. 13(6). 1512–1522. 113 indexed citations
10.
Nobles, Richard & David Schiff. (2013). Pulling Back from the Edge?. Modern Law Review. 76(3). 620–638.
11.
Nobles, Richard & David Schiff. (2010). Disobedience to Law – Debbie Purdy's Case. Modern Law Review. 73(2). 295–304. 4 indexed citations
12.
Prados, Michael, Timothy F. Cloughesy, Meghna Samant, et al.. (2010). Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology. 13(1). 143–151. 61 indexed citations
13.
Schiff, David, et al.. (2008). Cancer Neurology In Clinical Practice. Humana Press eBooks. 14 indexed citations
14.
Grimm, Sean, José S. Pulido, Kristoph Jahnke, et al.. (2007). Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Annals of Oncology. 18(11). 1851–1855. 188 indexed citations
15.
Nobles, Richard & David Schiff. (2006). Guilt and Innocence in the Criminal Justice System: A Comment on R (Mullen) v Secretary of State for the Home Department. Modern Law Review. 69(1). 80–91. 2 indexed citations
16.
Schiff, David & Patrick Y. Wen. (2002). Cancer Neurology in Clinical Practice. Humana Press eBooks. 6 indexed citations
17.
Schiff, David. (1997). Gershwin: Rhapsody in Blue. Cambridge University Press eBooks. 7 indexed citations
18.
Schiff, David & Lisa M. DeAngelis. (1994). Therapy of venous thromboembolism in patients with brain metastases. Cancer. 73(2). 493–498. 119 indexed citations
19.
Schiff, David. (1981). N.S. Timasheff'S Sociology Of Law. Modern Law Review. 44(4). 400–421. 2 indexed citations
20.
Schiff, David, J V Aranda, Eleanor Colle, & L Stern. (1971). Metabolic effects of exchange transfusion. II. Delayed hypoglycemia following exchange transfusion with citrated blood. The Journal of Pediatrics. 79(4). 589–593. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026